Neuroprotective Properties of Quetiapine versus Lithium in a First Episode Mania Cohort: 12-month Neuroanatomical, Neurochemical and Neuro-cognitive Effects and Preliminary Data of Prophylactic Properties
Phase of Trial: Phase IV
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Quetiapine (Primary) ; Lithium
- Indications Bipolar disorders; Schizoaffective disorder
- Focus Pharmacodynamics
- 02 Mar 2017 Status changed from recruiting to completed, according to results published in the British Journal of Psychiatry.
- 02 Mar 2017 Results published in the British Journal of Psychiatry.
- 25 Feb 2009 New trial record